Shandong New Time Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MONTELUKAST SODIUM USP, with a corresponding US DMF Number 33973.
Remarkably, this DMF maintains an Active status since its submission on August 13, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 21, 2021, and payment made on July 06, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II